UB Paderborn / Katalog / Suche / in CDI

1 – 17 von 17

Sortiert nach

Validation of a sensitive and specific real-time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients

Journal of medical virology, 2009-06, Vol.81 (6), p.988-995

2009

Link zum Volltext

Verfügbarkeit prüfen

753 BASELINE HBsAg PREDICTS HBsAg LOSS AFTER 2 YEARS OF TREATMENT-FREE FOLLOW-UP IN CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON alfa-2a AND ADEFOVIR

Journal of hepatology, 2013-04, Vol.58, p.S305-S305

2013

Link zum Volltext

Verfügbarkeit prüfen

Susceptibility of hepatitis B virus to lamivudine restored by resistance to adefovir

Journal of medical virology, 2009-03, Vol.81 (3), p.413-416

2009

Link zum Volltext

Verfügbarkeit prüfen

1242 LONG-TERM FOLLOW-UP OF CHRONIC HEPATITIS C INFECTED PATIENTS TREATED WITH TELAPREVIR: EVALUATION OF PERSISTENCE OF RESISTANT VARIANTS BY ULTRA-DEEP SEQUENCING

Journal of hepatology, 2011-03, Vol.54, p.S490-S491

2011

Link zum Volltext

Verfügbarkeit prüfen

1221 TREATMENT OUTCOME AND RESISTANCE ANALYSIS IN HCV GENOTYPE 1 PATIENTS PREVIOUSLY EXPOSED TO TMC435 MONOTHERAPY AND RE-TREATED WITH TMC435 IN COMBINATION WITH PEGIFNα-2A/RIBAVIRIN

Journal of hepatology, 2011-03, Vol.54, p.S482-S483

2011

Link zum Volltext

Verfügbarkeit prüfen

T-24 Retreatment with telaprevir/Peg-IFN/RBV after a short exposure to telaprevir in Phase I studies: interim results from a Phase IIIb rollover trial (C219)

Digestive and liver disease, 2012-02, Vol.44, p.S22-S22

2012

Link zum Volltext

Verfügbarkeit prüfen

746 NARLAPREVIR AND PEGINTERFERON ALFA-2B FOR 2 WEEKS IN CHRONIC HEPATITIS C GENOTYPE 1 PATIENTS, FOLLOWED BY PEGINTERFERON ALFA-2B AND RIBAVIRIN FOR 24/48 WEEKS: FINAL RESULTS

Journal of hepatology, 2010, Vol.52, p.S290-S291

2010

Link zum Volltext

Verfügbarkeit prüfen

629 UPTAKE OF HEPATITIS C SCREENING AND TREATMENT AMONG ACTIVE DRUG USERS IN AMSTERDAM: RESULTS OF THE DUTCH-C PROJECT (DRUG USERS TREATMENT FOR CHRONIC HEPATITIS C)

Journal of hepatology, 2009, Vol.50, p.S231-S231

2009

Link zum Volltext

Verfügbarkeit prüfen

O.1.1 Development of a new real-time PCR for the detection of covalently closed circular DNA (cccDNA) in plasma of chronic hepatitis B patients

Journal of clinical virology, 2009, Vol.44, p.S5-S5

2009

Link zum Volltext

Verfügbarkeit prüfen

O.1.2 Hepatitis B susceptibility to lamivudine restored by resistance to adefovir

Journal of clinical virology, 2009, Vol.44, p.S5-S5

2009

Link zum Volltext

Verfügbarkeit prüfen

P1884 Early prediction of response during high-dose interferon induction therapy in difficult-to-treat chronic hepatitis C patients

International journal of antimicrobial agents, 2007, Vol.29, p.S540-S540

2007

Link zum Volltext

Verfügbarkeit prüfen

P1885 Similar early viral kinetics of hepatitis C virus genotypes 1 and 4

International journal of antimicrobial agents, 2007, Vol.29, p.S540-S540

2007

Link zum Volltext

Verfügbarkeit prüfen

Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir

Scandinavian journal of gastroenterology, 2012-04, Vol.47 (4), p.475-481

2012

Link zum Volltext

Verfügbarkeit prüfen

P.249 Recurrence or persistence of HCV RNA detectable only by TMA during antiviral therapy

Journal of clinical virology, 2006, Vol.36, p.S139-S139

2006

Link zum Volltext

Verfügbarkeit prüfen

607 High incidence of de novo diabetes mellitus type 1 during or after treatment with pegylated interferon in patients with chronic hepatitis C virus infection

Journal of hepatology, 2006-04, Vol.44, p.S225-S225

2006

Link zum Volltext

Verfügbarkeit prüfen

Sexual transmission of hepatitis C virus

The Lancet (British edition), 1993-07, Vol.342 (8865), p.210-211

1993

Link zum Volltext

Verfügbarkeit prüfen

737 Initial results of a 14-day study of the hepatitis C virus inhibitor protease VX-950, in combination with peginterferon-alpha-2a

Journal of hepatology, 2006-04, Vol.44, p.S272-S272

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 17 von 17

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(17)

Sprache

Englisch
(17)
Japanisch
(2)

Erscheinungsjahr

n.n

Zeitschrift / Serie

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Validation of a sensitive and specific real-time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients

753 BASELINE HBsAg PREDICTS HBsAg LOSS AFTER 2 YEARS OF TREATMENT-FREE FOLLOW-UP IN CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON alfa-2a AND ADEFOVIR

Susceptibility of hepatitis B virus to lamivudine restored by resistance to adefovir

1242 LONG-TERM FOLLOW-UP OF CHRONIC HEPATITIS C INFECTED PATIENTS TREATED WITH TELAPREVIR: EVALUATION OF PERSISTENCE OF RESISTANT VARIANTS BY ULTRA-DEEP SEQUENCING

1221 TREATMENT OUTCOME AND RESISTANCE ANALYSIS IN HCV GENOTYPE 1 PATIENTS PREVIOUSLY EXPOSED TO TMC435 MONOTHERAPY AND RE-TREATED WITH TMC435 IN COMBINATION WITH PEGIFNα-2A/RIBAVIRIN

T-24 Retreatment with telaprevir/Peg-IFN/RBV after a short exposure to telaprevir in Phase I studies: interim results from a Phase IIIb rollover trial (C219)

746 NARLAPREVIR AND PEGINTERFERON ALFA-2B FOR 2 WEEKS IN CHRONIC HEPATITIS C GENOTYPE 1 PATIENTS, FOLLOWED BY PEGINTERFERON ALFA-2B AND RIBAVIRIN FOR 24/48 WEEKS: FINAL RESULTS

629 UPTAKE OF HEPATITIS C SCREENING AND TREATMENT AMONG ACTIVE DRUG USERS IN AMSTERDAM: RESULTS OF THE DUTCH-C PROJECT (DRUG USERS TREATMENT FOR CHRONIC HEPATITIS C)

O.1.1 Development of a new real-time PCR for the detection of covalently closed circular DNA (cccDNA) in plasma of chronic hepatitis B patients

O.1.2 Hepatitis B susceptibility to lamivudine restored by resistance to adefovir

P1884 Early prediction of response during high-dose interferon induction therapy in difficult-to-treat chronic hepatitis C patients

P1885 Similar early viral kinetics of hepatitis C virus genotypes 1 and 4

Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir

P.249 Recurrence or persistence of HCV RNA detectable only by TMA during antiviral therapy

607 High incidence of de novo diabetes mellitus type 1 during or after treatment with pegylated interferon in patients with chronic hepatitis C virus infection

Sexual transmission of hepatitis C virus

737 Initial results of a 14-day study of the hepatitis C virus inhibitor protease VX-950, in combination with peginterferon-alpha-2a

Suchergebnisse filtern